Patents Represented by Attorney, Agent or Law Firm John D. Quisel
  • Patent number: 6689563
    Abstract: The systems and methods described herein relate to nucleic acid probes comprising a a pattern of universal and designate nucleotides, or ‘gapped’ probes, and the use of sets of gapped probes in sequencing by hybridization to determine the sequence of nucleic acid sequences. The inclusion of universal nucleotides in the probes allows for efficient and rapid sequencing of longer nucleotide sequences than can be sequenced using traditional probes. The systems and methods described herein also relate to apparatus for sequencing nucleic acids which include gapped probes, as well as computer systems capable of analyzing data generated using gapped probes in such apparatus.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: February 10, 2004
    Assignee: Brown University Research Foundation
    Inventors: Franco P. Preparata, Eliezer Upfal
  • Patent number: 6437216
    Abstract: The present provides a mammal in which the expression of one or more interleukin genes has been suppressed. More specifically, the invention concerns the inactivating deletion of the interleukin-1 receptor antagonist gene to produce a knock-out non-human mammal with decreased or completely suppressed expression of the endogenous gene. The invention provides methods for preparing such knock-out mammals and methods of using the knock-out mammals to evaluate the effectiveness of therapeutic agents and regimens to treat diseases or disorders associated with perturbations in the interleukin pathways.
    Type: Grant
    Filed: March 12, 2001
    Date of Patent: August 20, 2002
    Assignee: Interleukin Genetics Inc.
    Inventors: Gordon W. Duff, Martin Nicklin
  • Patent number: 6383775
    Abstract: The invention provides a method for engineering and selecting an active protease able to cleave a user-defined target amino acid sequence. The method is useful for designing proteases for medical therapeutics and industrial applications.
    Type: Grant
    Filed: March 11, 1999
    Date of Patent: May 7, 2002
    Assignee: Interleukin Genetics, Inc.
    Inventors: Gordon W. Duff, Jon R. Sayers, Srdjan Vitovski